1
|
Saraswat N, Tripathy DM, Mishra A, Kumar A, Kartik S, Gopal MM. Tocilizumab for refractory post-COVID-19 pansclerotic morphea. J Eur Acad Dermatol Venereol 2024; 38:e364-e365. [PMID: 38078570 DOI: 10.1111/jdv.19692] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/19/2023] [Accepted: 11/22/2023] [Indexed: 04/26/2024]
Affiliation(s)
| | | | | | - Abhishek Kumar
- Medicine & Rheumatology, Army Hospital (R&R), New Delhi, India
| | - Sivasami Kartik
- Medicine & Rheumatology, Army Hospital (R&R), New Delhi, India
| | - Manoj M Gopal
- Pathology and Histopathology, Command Hospital, Lucknow, India
| |
Collapse
|
2
|
Benhayoun F, Hali F, El Fatoiki FZ, Chiheb S. COVID-19 and Autoimmunity in Dermatology: A Moroccan Case Series and Literature Review. Cureus 2024; 16:e57587. [PMID: 38707102 PMCID: PMC11069627 DOI: 10.7759/cureus.57587] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/03/2024] [Indexed: 05/07/2024] Open
Abstract
INTRODUCTION Since the beginning of the pandemic, many skin manifestations associated with COVID-19 have been reported. New reports show that COVID-19 can lead to autoimmune diseases (AIDs) and autoinflammatory diseases, especially dermatological. METHODS A prospective study was conducted by the dermatology department of the Centre Hospitalier Universitaire Ibn Rochd (CHU Ibn Rochd) of Casablanca in Morocco since the beginning of the pandemic including 18 patients with COVID-19-related skin manifestations. RESULTS Eighteen cases were collected with confirmed SARS-CoV-2 infection. The mean COVID score was 0.7. A percentage (94.44%) of the cases had general symptoms. Skin involvement was variable, mainly maculopapular rash (44.44%), purpura (27.77%), urticaria, varicelliform rash, necrotic lesions of the face, and pityriasis rosea Gibert (PRG)-like lesions. Mucosal involvement was found in 50%. Viral reactivation was found in 5.55%. Telogen effluvium was found in 22.22%. Moreover, AID was triggered by COVID-19: lupus (11.11%), associated with antiphospholipid syndrome (APL Sd) (5.55%), psoriasis (11.11%), alopecia, and pemphigus. Severe toxidermia was potentiated by SARS-CoV-2 infection (22.22%): Stevens-Johnson syndrome (Sd), acute generalized exanthematous pustulosis (APEG), and drug reaction with eosinophilia and systemic symptoms (DRESS). CONCLUSION The interest of this work is to report our experience during the COVID-19 pandemic to understand some pathophysiological mechanisms of its dermatological manifestations and to draw the attention of clinicians to the link of this infection with autoimmune and autoinflammatory diseases and toxidermia.
Collapse
Affiliation(s)
- Fatimazahrae Benhayoun
- Dermatology, Centre Hospitalier Universitaire Ibn Rochd (CHU Ibn Rochd), Casablanca, MAR
| | - Fouzia Hali
- Dermatology, Centre Hospitalier Universitaire Ibn Rochd (CHU Ibn Rochd), Casablanca, MAR
| | | | - Soumiya Chiheb
- Dermatology, Centre Hospitalier Universitaire Ibn Rochd (CHU Ibn Rochd), Casablanca, MAR
| |
Collapse
|
3
|
Harb M, Rached A, El Sayed F. Linear Morphea in the Context of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Unique Dermatological Manifestation. Cureus 2024; 16:e57031. [PMID: 38681264 PMCID: PMC11046374 DOI: 10.7759/cureus.57031] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 03/27/2024] [Indexed: 05/01/2024] Open
Abstract
Morphea, a rare skin disorder characterized by localized areas of thickened and sclerotic skin, typically presents as circumscribed plaques. The linear variant, however, manifests as linear bands of sclerosis affecting the extremities, and its association with coronavirus disease 2019 (COVID-19) has not been documented until now. In this article, we present the case of a 22-year-old previously healthy female patient who contracted COVID-19 complicated by an erythroedema on the back of the right hand, extending notably to the forearm on the 10th day of the infection. Skin biopsy revealed dermal and septal hypodermal fibrosis with a mild lymphocytic interstitial infiltrate in the dermis consistent with morphea. Treatment with low-dose corticosteroids was started, and regular follow-up was established. An isolated recurrence of cutaneous symptoms was observed after the first COVID-19 vaccination (Sputnik V) administered five months after the initial infection, with spontaneous regression in 10 days. This clinical evolution underscores the importance of a comprehensive understanding of dermatological manifestations in COVID-19, particularly in the context of post-infection vaccination.
Collapse
Affiliation(s)
- Mariam Harb
- Dermatology, Lebanese University Faculty of Medicine, Beirut, LBN
| | - Ahmad Rached
- Dermatology, Lebanese University Faculty of Medicine, Beirut, LBN
| | - Fouad El Sayed
- Dermatology, Lebanese University Faculty of Medicine, Beirut, LBN
| |
Collapse
|
4
|
Anstett S, Reginato AM, Elco C, Qureshi AA, Maher L. Boosting Awareness of Sclerotic Skin Diseases: Exploring the Inflammatory Overlap of Sclerotic Skin Disease and COVID-19 Vaccination. Arthritis Care Res (Hoboken) 2024; 76:164-170. [PMID: 37781743 DOI: 10.1002/acr.25251] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/10/2023] [Revised: 09/11/2023] [Accepted: 09/28/2023] [Indexed: 10/03/2023]
Affiliation(s)
- Sarah Anstett
- Rhode Island Hospital, Warren Alpert Medical School of Brown University, Providence
| | - Anthony M Reginato
- Rhode Island Hospital, Warren Alpert Medical School of Brown University, Providence
| | - Christopher Elco
- Rhode Island Hospital, Warren Alpert Medical School of Brown University, Providence
| | - Abrar A Qureshi
- Rhode Island Hospital, Warren Alpert Medical School of Brown University, Providence
| | - Lewena Maher
- Rhode Island Hospital, Warren Alpert Medical School of Brown University, Providence
| |
Collapse
|
5
|
Alhayaza R, Alhayaza G, Algarni A, Alhumidi A, AlHarithy R. Generalized morphea following COVID-19 vaccine: Case report and literature review. Clin Case Rep 2023; 11:e7133. [PMID: 37006851 PMCID: PMC10062313 DOI: 10.1002/ccr3.7133] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/12/2023] [Revised: 03/03/2023] [Accepted: 03/13/2023] [Indexed: 04/04/2023] Open
Abstract
Physicians should be vigilant for COVID-19 vaccine side effects and investigate any associated cutaneous manifestations. This will ultimately facilitate better understanding and recognition of various skin reactions related to the vaccine.
Collapse
Affiliation(s)
- Raid Alhayaza
- College of MedicineAlfaisal UniversityRiyadhSaudi Arabia
| | - Ghada Alhayaza
- Department of Dermatology and Dermatologic SurgeryPrince Sultan Military Medical CityRiyadhSaudi Arabia
| | - Abdullah Algarni
- Department of DermatologyKing Saud Medical CityRiyadhSaudi Arabia
| | - Ahmed Alhumidi
- Department of PathologyKing Saud UniversityRiyadhSaudi Arabia
| | - Ruaa AlHarithy
- College of MedicinePrincess Nourah Bint Abdulrahman UniversityRiyadhSaudi Arabia
- Department of DermatologySecurity Forces HospitalRiyadhSaudi Arabia
| |
Collapse
|
6
|
Paolino G, Campochiaro C, Di Nicola M, Mercuri S, Rizzo N, Dagna L, Rongioletti F, De Luca G. Generalized morphea after COVID-19 vaccines: a case series. J Eur Acad Dermatol Venereol 2022; 36:e680-e682. [PMID: 35604052 PMCID: PMC9348393 DOI: 10.1111/jdv.18249] [Citation(s) in RCA: 10] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/08/2022] [Accepted: 05/18/2022] [Indexed: 11/30/2022]
Affiliation(s)
- G. Paolino
- Unità di Dermatologia ClinicaVita‐Salute San Raffaele UniversityMilanItaly
- Unit of Dermatology and CosmetologyIRCCS San Raffaele HospitalMilanItaly
| | - C. Campochiaro
- Unit of Immunology, Rheumatology, Allergy and Rare DiseasesIRCCS San Raffaele HospitalMilanItaly
| | - M.R. Di Nicola
- Unit of Dermatology and CosmetologyIRCCS San Raffaele HospitalMilanItaly
| | - S.R. Mercuri
- Unit of Dermatology and CosmetologyIRCCS San Raffaele HospitalMilanItaly
| | - N. Rizzo
- Surgical PathologyIRCCS San Raffaele HospitalMilanItaly
| | - L. Dagna
- Unit of Immunology, Rheumatology, Allergy and Rare DiseasesIRCCS San Raffaele HospitalMilanItaly
- Vita‐Salute San Raffaele UniversityMilanItaly
| | - F. Rongioletti
- Unità di Dermatologia ClinicaVita‐Salute San Raffaele UniversityMilanItaly
| | - G. De Luca
- Unit of Immunology, Rheumatology, Allergy and Rare DiseasesIRCCS San Raffaele HospitalMilanItaly
| |
Collapse
|
7
|
Florenzo B, Martin S, Saavedra A. Reactivated chronic graft-versus-host disease following SARS-CoV-2 infection. JAAD Case Rep 2022; 26:76-78. [PMID: 35789677 PMCID: PMC9242890 DOI: 10.1016/j.jdcr.2022.06.015] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
Affiliation(s)
- Brian Florenzo
- Department of Dermatology, University of Virginia School of Medicine, Charlottesville, Virginia
| | - Seth Martin
- Department of Dermatology, University of Virginia Medical Center, Charlottesville, Virginia
| | - Arturo Saavedra
- Department of Dermatology, University of Virginia Medical Center, Charlottesville, Virginia
| |
Collapse
|
8
|
Metin Z, Celepli P. A case of morphea following the COVID-19 mRNA vaccine: on the basis of viral spike proteins. Int J Dermatol 2022; 61:639-641. [PMID: 35073411 DOI: 10.1111/ijd.16062] [Citation(s) in RCA: 7] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/17/2021] [Revised: 12/09/2021] [Accepted: 12/30/2021] [Indexed: 01/08/2023]
Affiliation(s)
- Zuhal Metin
- Department of Dermatology, Zonguldak Ataturk State Hospital, Zonguldak, Turkey
| | - Pinar Celepli
- Department of Pathology, Ankara Training and Research Hospital, Ankara, Turkey
| |
Collapse
|
9
|
Behrangi E, Sadeghzadeh‐Bazargan A, Salimi N, Shaka Z, Feyz Kazemi MH, Goodarzi A. Erythrodermic flare‐up of psoriasis with COVID‐19 infection: A report of two cases and a comprehensive review of literature focusing on the mutual effect of psoriasis and COVID‐19 on each other along with the special challenges of the pandemic. Clin Case Rep 2022; 10:e05722. [PMID: 35474976 PMCID: PMC9019895 DOI: 10.1002/ccr3.5722] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/30/2021] [Revised: 03/12/2022] [Accepted: 03/28/2022] [Indexed: 12/11/2022] Open
Affiliation(s)
- Elham Behrangi
- Department of Dermatology Rasool Akram Medical Complex Clinical Research Development Center (RCRDC) School of Medicine Iran University of Medical Sciences (IUMS) Tehran Iran
| | - Afsaneh Sadeghzadeh‐Bazargan
- Department of Dermatology Rasool Akram Medical Complex Clinical Research Development Center (RCRDC) School of Medicine Iran University of Medical Sciences (IUMS) Tehran Iran
| | - Nastaran Salimi
- School of Medicine Iran University of Medical Sciences Tehran Iran
| | - Zoha Shaka
- School of Medicine Iran University of Medical Sciences Tehran Iran
- Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA) Universal Scientific Education and Research Network (USERN) Tehran Iran
| | | | - Azadeh Goodarzi
- Department of Dermatology Rasool Akram Medical Complex Clinical Research Development Center (RCRDC) School of Medicine Iran University of Medical Sciences (IUMS) Tehran Iran
| |
Collapse
|
10
|
Aryanian Z, Balighi K, Hatami P, Tootoonchi NM, Goodarzi A, Mohseni Afshar Z. Morphea in two patients after being infected to and being vaccinated against SARS‐CoV‐2 infection. Clin Case Rep 2022; 10:e05667. [PMID: 35449768 PMCID: PMC9014706 DOI: 10.1002/ccr3.5667] [Citation(s) in RCA: 12] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/05/2022] [Accepted: 03/20/2022] [Indexed: 12/17/2022] Open
Abstract
Although the presence of morphea following COVID‐19 has been rarely reported, the development of its generalized form following COVID‐19 vaccination has not been reported yet. Here, we reported the first case of generalized morphea following COVID‐19 vaccination and another similar case following SARS‐Cov‐2 infection. Other etiologic factors were also dealt with.
Collapse
Affiliation(s)
- Zeinab Aryanian
- Autoimmune Bullous Diseases Research Center Tehran University of Medical Sciences Tehran Iran
- Department of Dermatology Babol University of Medical Sciences Babol Iran
| | - Kamran Balighi
- Autoimmune Bullous Diseases Research Center Tehran University of Medical Sciences Tehran Iran
- Department of Dermatology Razi Hospital Tehran University of Medical Sciences Tehran Iran
| | - Parvaneh Hatami
- Autoimmune Bullous Diseases Research Center Tehran University of Medical Sciences Tehran Iran
| | - Nasim Mazloumi Tootoonchi
- Autoimmune Bullous Diseases Research Center Tehran University of Medical Sciences Tehran Iran
- Department of Dermatology Razi Hospital Tehran University of Medical Sciences Tehran Iran
| | - Azadeh Goodarzi
- Department of Dermatology Rasoul‐e‐Akram Hospital Iran University of Medical Sciences Tehran Iran
- Skin and Stem Cell Research Center Tehran Iran
| | - Zeinab Mohseni Afshar
- Clinical Research Development Center Imam Reza Hospital Kermanshah University of Medical Sciences Kermanshah Iran
| |
Collapse
|
11
|
Pour Mohammad A, Mashayekhi F, Seirafianpour F, Gholizadeh Mesgarha M, Goodarzi A. COVID‐19 and COVID‐19 vaccine‐related dermatological reactions: An interesting case series with a narrative review of the potential critical and non‐critical mucocutaneous adverse effects related to virus, therapy, and the vaccination. Clin Case Rep 2022; 10:e05775. [PMID: 35498347 PMCID: PMC9040420 DOI: 10.1002/ccr3.5775] [Citation(s) in RCA: 10] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/24/2022] [Revised: 03/07/2022] [Accepted: 03/08/2022] [Indexed: 12/18/2022] Open
Abstract
This narrative review article was conducted to lay out a summarized but exhaustive review of current literature over mucocutaneous manifestations in 4 dimensions of SARS‐CoV‐2 pandemic: virus itself, treatment‐related, vaccine‐induced, and alteration of chronic dermatologic diseases following infection. Virus and vaccine‐related were mainly self‐limited and non‐severe. Treatment‐related reactions could be life‐threatening.
Collapse
Affiliation(s)
| | - Farzaneh Mashayekhi
- Department of General Medicine Rasool Akram Medical Complex Iran University of Medical Sciences (IUMS) Tehran Iran
| | - Farnoosh Seirafianpour
- Student Research Committee School of Medicine Iran University of Medical Sciences Tehran Iran
| | | | - Azadeh Goodarzi
- Department of Dermatology Rasool Akram Medical Complex Clinical Research Development Center (RCRDC) School of Medicine Iran University of Medical Sciences Tehran Iran
| |
Collapse
|
12
|
Seirafianpour F, Pourriyahi H, Mesgarha MG, Pour Mohammad A, Shaka Z, Goodarzi A. A systematic review on mucocutaneous presentations after COVD-19 vaccination and expert recommendations about vaccination of important immune-mediated dermatologic disorders. Dermatol Ther 2022; 35:e15461. [PMID: 35316551 PMCID: PMC9111423 DOI: 10.1111/dth.15461] [Citation(s) in RCA: 23] [Impact Index Per Article: 11.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/25/2021] [Revised: 03/14/2022] [Accepted: 03/17/2022] [Indexed: 11/29/2022]
Abstract
With dermatologic side effects being fairly prevalent following vaccination against COVID-19, and the multitude of studies aiming to report and analyze these adverse events, the need for an extensive investigation on previous studies seemed urgent,in order to provide a thorough body of information about these post-COVID-19 immunization mucocutaneous reactions. To achieve this goal, a comprehensive electronic search was performed through the international databases including Medline (PubMed), Scopus, Cochrane, Web of science, and Google scholar on July 12, 2021, and all articles regarding mucocutaneous manifestations and considerations after COVID-19 vaccine administration were retrieved using the following keywords: COVID-19 vaccine, dermatology considerations and mucocutaneous manifestations. A total of 917 records were retrieved and a final number of 180 articles were included in data extraction. Mild, moderate, severe and potentially life-threatening adverse events have been reported following immunization with COVID vaccines, through case reports, case series, observational studies, randomized clinical trials, and further recommendations and consensus position papers regarding vaccination. In this systematic review, we categorized these results in detail into five elaborate tables, making what we believe to be an extensively informative, unprecedented set of data on this topic. Based on our findings, in the viewpoint of the pros and cons of vaccination, mucocutaneous adverse events were mostly non-significant, self-limiting reactions, and for the more uncommon moderate to severe reactions, guidelines and consensus position papers could be of great importance to provide those at higher risks and those with specific worries of flare-ups or inefficient immunization, with sufficient recommendations to safely schedule their vaccine doses, or avoid vaccination if they have the discussed contra-indications. This article is protected by copyright. All rights reserved.
Collapse
Affiliation(s)
- Farnoosh Seirafianpour
- Student Research Committee, School of Medicine, Iran University of Medical Sciences (IUMS), Tehran, Iran
| | - Homa Pourriyahi
- Student Research Committee, School of Medicine, Iran University of Medical Sciences (IUMS), Tehran, Iran
| | | | - Arash Pour Mohammad
- Student Research Committee, School of Medicine, Iran University of Medical Sciences (IUMS), Tehran, Iran
| | - Zoha Shaka
- Faculty of Medicine, Iran University of Medical Sciences (IUMS), Tehran, Iran.,Systematic Review and Meta-Analysis Expert Group (SRMEG), Universal Scientific Education and Research Network (USERN), Tehran, Iran
| | - Azadeh Goodarzi
- Department of Dermatology, Rasool Akram Medical Complex Clinical Research Development Center (RCRDC), School of Medicine, Iran University of Medical Sciences (IUMS), Tehran, Iran
| |
Collapse
|
13
|
Kalantari Y, Sadeghzadeh-Bazargan A, Aryanian Z, Hatami P, Goodarzi A. First reported case of delayed-type hypersensitivity reaction to non-hyaluronic acid Polycaprolactone dermal filler following COVID-19 vaccination: A case report and a review of the literature. Clin Case Rep 2022; 10:e05343. [PMID: 35145687 PMCID: PMC8818279 DOI: 10.1002/ccr3.5343] [Citation(s) in RCA: 14] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/30/2021] [Revised: 01/01/2022] [Accepted: 01/13/2022] [Indexed: 12/23/2022] Open
Abstract
Cases of filler reactions after COVID‐19 vaccination have been reported. Here, we present the first case of delayed‐type reaction (DTR) to non‐hyaluronic acid Polycaprolactone dermal filler after the second dose of Sinopharm COVID‐19 vaccine which was improved with administration of topical and intralesional steroids.
Collapse
Affiliation(s)
- Yasamin Kalantari
- Department of Dermatology Razi Hospital Tehran University of Medical Sciences Tehran Iran
| | - Afsaneh Sadeghzadeh-Bazargan
- Rasool Akram Medical Complex Clinical Research Development Center (RCRDC) School of Medicine Iran University of Medical Sciences Tehran Iran
| | - Zeinab Aryanian
- Autoimmune Bullous Diseases Research Center Tehran University of Medical Sciences Tehran Iran.,Department of Dermatology Babol University of Medical Sciences Babol Iran
| | - Parvaneh Hatami
- Autoimmune Bullous Diseases Research Center Tehran University of Medical Sciences Tehran Iran
| | - Azadeh Goodarzi
- Rasool Akram Medical Complex Clinical Research Development Center (RCRDC) School of Medicine Iran University of Medical Sciences Tehran Iran.,Skin and Stem Cell Research Center Tehran University of Medical Sciences Tehran Iran
| |
Collapse
|